Real-world effectiveness of nab-paclitaxel plus carboplatin as first-line therapy for patients with advanced NSCLC: Results of the second interim analysis of the NEPTUN study. Artificial ...
Retrospective review of doxorubicin plus sorafenib as second-line therapy in hepatocellular carcinoma (HCC). Background: We have previously reported outcome of concurrent chemoradiotherapy (CCRT) in ...
All biopsies were between the time interval of 2001 to 2011 and had been performed within 6 months of liver transplantation. The study group was post-transplant liver biopsy specimens with the pattern ...
We conducted a retrospective study in all patients who underwent allo-HCT between 2005 and 2011 at our institution and subsequently developed NRP. NRP was defined as presence of ⩾3 g of protein in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results